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Available online 29 February 2008Ceramide-induced alterations in the lateral organization of membrane proteins can be involved in several
biological contexts, ranging from apoptosis to viral infections. In order to investigate such alterations in a simple
model, we used a combined approach of atomic forcemicroscopy, scanningﬂuorescence correlation spectroscopy
andconfocalﬂuorescence imaging to study the partitioningof differentmembrane components in sphingomyelin/
dioleoyl-phosphatidylcholine/cholesterol/ceramide supported bilayers. Such model membranes exhibit
coexistence of liquid-disordered, liquid-ordered (raft-like) and ceramide-rich lipid phases. Our results show that
components with poor afﬁnity toward the liquid-ordered phase, such as several ﬂuorescent lipid analogues or the
synapticprotein Synaptobrevin2, are excluded fromceramide-richdomains. Conversely,we show for theﬁrst time
that the raft-associated protein placental alkaline phosphatase (GPI-PLAP) and the ganglioside GM1 are enriched in
such domains, while exhibiting a strong decrease in lateral diffusion. Analogue modulation of the local
concentration and dynamics of membrane proteins/receptors by ceramide can be of crucial importance for the
biological functions of cell membranes.







Atomic force microscopy1. Introduction
In the last decade, experimental evidence has led to the hypothesis
that cell membrane constituents might be organized in small lipid/
protein domains enriched in sphingomyelin (SM) and cholesterol, known
as “rafts” [1,2]. The physical state of these domains is considered to be
similar to a liquid-ordered (Lo) phase, structurally and dynamically dis-
tinct from the rest of the lipid bilayerwhich is, in turn, assumed to be in a
liquid-disordered phase (Ld) [3]. Lipid microdomains are thought to be
involved in various biological processes such as protein and lipid sorting
for cell–cell communication or intracellular signaling cascades [4].
Several studies have identiﬁed a novel membrane domain based on
the sphingolipid ceramide,which plays an important role in amultitude
of cellular processes ranging from differentiation to immune response
and apoptosis [5–7]. Because of its unusual biophysical properties [8,5],
ceramide molecules display a tendency to separate from the rest of the
membrane, forming gel-phase, ceramide-rich domains [5,6], both in
cells [9] and in model membranes [10–12]. In particular, such domains
were also observed when ceramide was added or produced in bilayers
that showed coexisting Ld/Lo, raft-like phase separation [13–15]. It is
important to stress that, at least in the context of simple model mem-
brane systems, it is possible to distinguish “lipid rafts”, which are Lo-51, 01307 Dresden, Germany.
(P. Schwille).
ll rights reserved.domains enriched in SMand cholesterol, from “ceramide-richdomains”,
highly ordered gel domains that probably exclude cholesterol [16,17].
The interplay between rafts and ceramide domains is thought to be
involved in the internalization of viruses and parasites and in the in-
duction of apoptosis [18]. Ceramide-rich platforms may act in these
situations as sorting locations for membrane receptors, inhibitors and
other membrane components involved in signaling [19]. For example,
ceramide-rich domains seem to recruit the receptors mediating the
internalization ofNeisseria gonorrhoeae [20]. Similar receptor clustering
and trapping in ceramide-richdomains is also suggested byexperiments
performed with Fcγ receptor II [21], CD95 and CD40 [22,23]. Never-
theless, since the ceramide phase is characterized by tight packing of
lipids and high structural order, it seems counter-intuitive that certain
membrane proteins would partition strongly into these rigid domains
[15]. Until now, no biophysical study concerning the afﬁnity of mem-
brane proteins or sphingolipids (other than SM and ceramide) for the
ceramide-rich domains has been reported.
In order to address this question, we used a combined approach of
atomic force microscopy (AFM), ﬂuorescence imaging, and scanning
ﬂuorescence correlation spectroscopy (scanning FCS) to study the
partitioning of membrane components into different lipid phases. Spe-
ciﬁcally, we produced supported bilayers showing a coexistence of Ld
phase, Lo raft-like phase and ceramide-rich gel phase. We investigated
the lateral organization of Ld-associated membrane components — i.e.
ﬂuorescent lipid analogues and the synaptic membrane protein Synap-
tobrevin 2 — and two typical raft-associated membrane components —
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phosphatase (GPI-PLAP), and cholera toxin (CTx-B) bound to GM1. In
order to obtain quantitative data about the partitioning of ﬂuorescent
molecules into the different lipid phases, we used a novel technique
based on scanning FCS. FCS was already successfully employed to study
dynamics in lipid membranes [24], and calibration-free techniques like
2-focus FCS [25] and z-scan FCS [26] were shown to provide precise and
reliable diffusion coefﬁcients. Use of scanning FCS, differently from the
above described FCS approaches, makes it possible to obtain reliable
data even in the case of very slow diffusion and strong bleaching of the
membrane components which are present in the highly viscous regions
of themembrane, such as the ceramide-rich domains. Furthermore, FCS
in general allows us to neglect changes in brightness of the ﬂuorophores
in different lipid environments that arise because of selective excitation,
quenching or environmental sensitivity.
Our results show that membrane components with a low capacity
to partition into the raft-like Lo phase tend to be completely excluded
from the tightly packed ceramide domains. On the contrary, GPI-PLAP
and CTx-B, which usually show a remarkably high degree of parti-
tioning into the Lo phase1, seem to be concentrated in the ceramide-
rich phase. Nevertheless, the afﬁnity for the Lo phase is not by itself
sufﬁcient for the inclusion in ceramide domains, as exempliﬁed by the
case of the novel ﬂuorescent free cholesterol analogue BODIPY-FChol.
Furthermore, while the addition of ceramide does not appreciably
change the dynamic properties of the membrane components in the
Ld and Lo phases, very slow (bb0.1 µm2/s) diffusion is observed for the
proteins enriched in the ceramide phase. These ﬁndings strongly
support the hypothesis that ceramide domains may act in vivo as
protein/lipid platforms that recruit or exclude speciﬁc membrane
components (e.g. from small transient rafts), clustering them stably
together and effectively slowing their in-plane diffusion.
2. Materials and methods
2.1. Chemicals
1,2-dioleoyl-sn-glycero-3-phosphocholine (dioleoyl-phosphatidylcholine; DOPC), N-
stearoyl-D-erythro-sphingosylphosphorylcholine (N-stearoyl sphingomyelin; SM), N-stear-
oyl-D-erythro-sphingosine (C18:0 ceramide, C18-Cer), Galβ1-3GalNAcβ1-4(NeuAcα2-3)
Galβ1-4Glcβ1-1′-Cer (GM1 ganglioside, GM1) and cholesterol were purchased from Avanti
Polar Lipids (Alabaster, AL) and used without further puriﬁcation. BODIPY free cholesterol
analogue 23-(4,4-diﬂuoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacen-8-yl)-24-
norchol-5-en-3β-ol (BODIPY-FChol) was synthesized as described for “compound 2” in
[28]. Dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate (DiD-C18, DiD),
cholesteryl 4,4-diﬂuoro-5, 7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-dodecanoate
(cholesteryl ester BODIPY FL C12,, BODIPY-CholE) and Alexa Fluor 488 cholera toxin subunit
B (CTx-B) were from Invitrogen (Eugene, OR). Optical Adhesive 88, used to glue themica on
coverslips, was purchased from Norland Products (Cranbury, NJ). Alkaline phosphatase
from human placental tissue (PLAP), 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonic acid (CHAPS) and sodium cholate were purchased from Sigma. Before
use, PLAP was puriﬁed and labelled with NHS-rhodamine (Pierce, Rockford, IL) using a
protocolmodiﬁed from [29] and [30]. In particular, high-resolution Superdex20010/300GL
(GE-Healthcare) columnswere used instead of Sephacryl S200 and, after labelling, a Nap-5
(GE-Healthcare) and an additional Superdex columns were used to exclude free dye and
protein dimers.
Recombinant protein Synaptobrevin 2 (residues 1–117C) was expressed, puriﬁed and
labeled with Cy5 maleimide (Amersham Biosciences) as described in [31] and [32].Three
different bufferswere used for sample preparation and imaging: buffer A (3mMKCl,1.5mM
KH2PO4, 8mMNa2HPO4,150mMNaCl, pH 7.2); buffer B (3mMCaCl2,150mMNaCl,10mM
Hepes, 3mMNaN3, pH 7.4); and buffer C (150mMNaCl,10mMHepes, 3mMNaN3, pH 7.4).
All buffers were ﬁltered through a 0.2-µm ﬁlter (Nalgene, Rochester, NY) prior to use.
2.2. Supported lipid bilayers (SLBs)
Planar bilayers were prepared based on the procedure described by Chiantia et al. [33].
Brieﬂy, lipids and ﬂuorescent lipid analogues were mixed in organic solvents in different
proportions. The lipid compositionwasDOPC:SM:Cer:Cholesterol 1:0.7:0.3:0.67molar ratio.
In other terms, the concentrations of cholesterol and Cer were 25 and ~10mol% of the lipid
mixture, respectively. The concentration of ﬂuorescent lipid analogues was always 0.1 or
0.01 mol%, for imaging and FCS, respectively. After solvent evaporation, the lipid ﬁlm thus1 Compared to other lipid analogues and membrane proteins like SNAREs and
Bacteriorhodopsin [27].obtained was slowly rehydrated using buffer A at 10 mg/mL lipid concentration and
resuspended by vigorous vortexing. After sonication of the suspension at 60 °C, a small
aliquot was diluted in buffer B and deposited on a ~10-µm thick, freshly cleavedmica, glued
to a glass coverslip. The coverslip was sealed in the temperature-controlled Biocell stage
(JPK Instruments, Berlin, Germany), transferred to the microscope and incubated at 55 °C
for 5 min. The sample was rinsed at the same temperature at least 10 times with buffer C
and thenallowed to cool to 25 °C. Samples containingCerwere generally unstableafter ~3h.
For this reason, all themeasurements were performed within before ~1 h after the cooling
phase.
2.3. Protein-containing SLBs
In the case of membranes containing rhodamine-labeled PLAP, the liposomes were
used to produce proteoliposomes before deposition onto mica, using a modiﬁcation of
the procedure described by Kahya et al. [29] In particular, the protein and 100 nm
extruded liposomes (without ceramide) were mixed in buffer A to ﬁnal concentrations
of 40 µg/mL and 2.5 mg/mL, respectively, in the presence of 1.8% CHAPS. The liposomes'
extrusion was performed twice: i) before adding CHAPS and ii) before adding the
protein. The initial protein:lipid ratiowas ~1:2500. After 24 h of dialysis against buffer A
using a 50 kDa SpectraPro membrane (Spectrum, Breda, Netherlands), a small aliquot
was diluted 10 times in buffer B, brieﬂy sonicated with ceramide-containing liposomes
in the desired proportions at 50 °C, and deposited onto mica as described above for the
normal, protein-free, liposomes. The ﬁnal protein:lipid ratio was then ~1:8000. The
activity of the reconstituted protein was checked by enzymatic digestion of Sigma Fast
p-nitrophenyl phosphate (Sigma) in the solution above the SLB.
SLBs containingSynaptobrevin2wereprepared fromproteoliposomesasdescribedby
Bacia et al. [31]. In particular, the protein and 100 nm extruded liposomes (without
ceramide)weremixed inbufferAwith ~1:2500molar ratio, in thepresenceof 1.2% sodium
cholate. The liposomes' extrusion was performed twice: i) before adding sodium cholate
and ii) before adding the protein. After 24 h of dialysis against buffer A using a 50 kDa
SpectraPro membrane (Spectrum, Breda, Netherlands), a small aliquot was diluted 10
times in buffer B, brieﬂy sonicated with ceramide-containing liposomes in the desired
proportions at 50 °C, and deposited onto mica as described above for the normal, protein-
free liposomes. The ﬁnal protein:lipid ratio was ~1:8500. The activity of the protein
incorporated in the SLBwas checked by speciﬁc binding to a ﬂuorescent soluble syntaxing
fragment (AA 183–262) [31].
In the case of samples stained with Alexa488 CTx-B, the SLBs contained 0.03% GM1.
The toxin (10 mg/mL) was added and washed away after 2 min incubation.
2.4. Optical setup
Confocal imaging and scanning FCS measurements were performed on an laser
scanning microscope (LSM) Meta 510 system (Carl Zeiss, Jena, Germany) using a 40× NA
1.2 UV-VIS-IR C Apochromat water-immersion objective and a home-built detection
unit at the ﬁber output channel. An appropriate band-pass ﬁlter was used behind a
collimating achromat to reject the residual laser and background light. Another
achromat (LINOS Photonics, Goettingen, Germany) with a shorter focal length was used
to image the internal pinhole onto the aperture of the ﬁber connected to the avalanche
photo diode (APD, PerkinElmer, Boston, MA). The photon arrival times were recorded in
the photon mode of the hardware correlator Flex 02-01D (Correlator.com, Bridgewater,
NJ). All ﬁlters and dichroic mirrors were purchased from AHF Analyse Technik,
Tuebingen, Germany. The movement of the detection volume was controlled directly
with the Zeiss LSM operation software.
2.5. Scanning FCS
Data were acquired by scanning repeatedly the focal volume in a linear fashion in
the membrane. Line scans of ca. 5-µm length were chosen such that all three phases
were scanned through. Intensity traces of parts of the scans corresponding to only one
phase were correlated scan by scan. To account for photo bleaching, correlation curves
Gi(τ) were multiplied by the ratio between the average intensity of the corresponding
scan Ii and the initial intensity I0: G˜i(τ)=Gi(τ) · I / I0. Since the concentrations ci are
inversely proportional to amplitudes of the correlation curves (i.e. Gi(0)~1/ci) and
directly proportional to the intensities (Ii~ci,), G˜i(τ) is in this way scaled back to the
initial correlation curve G0(τ). The average of the rescaled correlation curves was ﬁtted
with a ﬂow-diffusion model. Since the residence time of the scanned detection volume
is much shorter than the diffusion time, the diffusional part of the correlation curves
was very small. Therefore diffusion coefﬁcients could be ﬁxed to approximate value. By
using the known velocity of the detection volume, the ﬁt provided directly the size of
the detection volume w0 and, more importantly, the ﬂuorophore concentration c.
Knowing the concentration of the ﬂuorophores in the different phases (cLo, cLd, and cCer),
we deﬁned a “normalized partition” PX for the phase X as:
PX ¼ cXcLo þ cLd þ cCer
ð1Þ
In the case of samples without ceramide, PX is simply:
PX ¼ cXcLo þ cLd
ð2Þ
Fig. 1. Synaptobrevin 2 is excluded from ceramide-rich domains. A) AFM topographical
image of a SM/DOPC/ceramide/cholesterol supported bilayer containing Synaptobrevin
2 at 25 °C. The three topographical level in the ﬁgure represent the Ld (black, number 1),
Lo (dark grey, number 2), and ceramide-enriched phase (light grey, number 3)
respectively. The protein can be visualized as bright white protrusions, a few nm higher
than the lipid membrane, probably corresponding to small clusters of up to ~10
Synaptobrevin 2 monomers. The circles show the ceramide-rich domains. The arrow
indicates a Synaptobrevin 2 cluster in the Lo phase, surrounded by a thinner portion of
membrane. B) Representative APD measurements of the ﬂuorescence signal of the
protein as a function of time in the Ld (1), Lo (2) and ceramide-rich (3) phases.
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AFMmeasurements were performed using a NanoWizard system (JPK Instruments,
Berlin, Germany) mounted on the LSM Meta 510 system described in the optical setup
paragraph. Contact-mode topographic images were taken in the constant-deﬂection
mode using uncoated silicon cantilevers (MikroMasch, Spain) with a typical spring
constant of 0.03 Nm−1. For the intermittent contact imaging, analogous cantilevers with
a typical spring constant of 0.08 Nm were used. The force applied on the sample was
maintained at the lowest possible value by continuously adjusting the set point during
imaging. For non-contact imaging, the cantilever oscillationwas tuned to a frequency of
5–10 kHz, and the maximum amplitude was set to 0.1–0.15 V (5–7.5 nm). The scan rate
was set to 1–2 Hz for contact mode and 0.7–1 Hz for intermittent contact mode. The
height, deﬂection, and phase-shift signals were collected simultaneously in both trace
and retrace directions. Images were line-ﬁtted as required. Isolated scan lines were
occasionally removed.
3. Results and discussion
3.1. Ld-associated protein Synaptobrevin is excluded from ceramide domains
Synaptobrevin 2 belongs to the SNARE protein family, which is in-
volved in the membrane fusion processes within the secretory pathway
of eukaryotic cells. The lateral organization of SNARE proteins in the
plasmamembrane and their association to raft domains in vivo are still
matter of debate [34–36]. The determination of the afﬁnity of a mem-
brane component for raft domains often relies on detergent-resistance
assays at low temperature. These procedures are in general prone to
artifacts [37] and, in the case of Synaptobrevin for example, the outcome
can be even inﬂuenced by the choice of the speciﬁc detergent [38]. On
the other hand, studies with model membranes clearly show that both
Syntaxin 1 and Synaptobrevin 2 are preferentially associatedwith the Ld
phase in lipid bilayers composed of DOPC, SM, and cholesterol [31,39].
For this reason,we chose the samerecombinant Synaptobrevin 2used in
Ref. [31] as a paradigm for a Ld-associated membrane component. In
order to study its lateral organization in the presence of ceramide
domains, we reconstituted Synaptobrevin 2 in supported bilayers sho-
wing a Ld/Lo/ceramide-rich phase coexistence.
We used membranes containing DOPC, SM, C18:0 ceramide, and
cholesterol in a 1:0.7:0.3:0.67 molar ratio. Fig. 1A shows an AFM topo-
graphical image of such amembrane, inwhich the three lipid phases can
be distinguished based on the increasing thickness. The activity of the
protein was veriﬁed as described in the Materials and methods section.
Aswaspreviously shown[13,40], in suchsupportedbilayers theLo phase
is ~0.8 nm higher than the Ld phase, and the ceramide-rich phase is
~1.3 nm higher than the Ld phase. Fig. 1A shows the Ld phase as the
darkest portions of the membrane, the Lo phase as a dark grey area and
the ceramide-rich domains as light grey domains (evidenced by circles).
Synaptobrevin reconstituted in the bilayer appears as small round spots,
1.2–2.0 nm higher than the rest of the membrane, which are not ob-
served in pure lipid bilayers prepared under the same conditions [13].
The average radius of these spots, measured at half height to minimize
the error introduced by the geometry of the scanning tip [41], is 15–
20 nm. In line with previous observations regarding Syntaxin 1 recons-
tituted in lipid bilayers [42], this result suggests that the round spots
visualized by AFM are small immobile Synaptobrevin clusters, contain-
ing in this case approximatively ~10monomers each. Fig.1A shows that
these clusters are observed mostly in the Ld phase, while they are
completely excluded from the ceramide-rich domains. As it was pointed
out in a recent work from our group [33], AFMmight not be themethod
of choice for proteinpartition studies because small diffusingmembrane
components (e.g., Synaptobrevinmonomers)might be undetected. AFM
is used here to: i) correctly identify ceramide-rich and Lo domains and ii)
monitor the presence of large aggregates of membrane proteins, espe-
cially in the ceramide-rich phase. Although the presence of immobile
Synaptobrevin in the highly viscous ceramide domains should be easily
detected by AFM, a complementary technique is necessary to conﬁrm
the absence of protein in these domains.
Because of the low protein concentration, LSM imaging does not
convey a clear contrast between the different lipid phases (data notshown). Fluorescence imaging performed using highly sensitive APDs
shows that the signal originating from Synaptobrevin 2 in both the Ld
and the Lo phase is signiﬁcantly higher than that from the protein in the
ceramide domains, the latter being comparable to background noise of
ca. 300–400 photons per second (see Fig.1B). The extremely lowprotein
signal in the ceramide-richphaseprecludes thepossibilityof performing
further quantitative measurement (i.e. scanning FCS) of the protein
partition behavior. Nevertheless, it is possible to conclude that the con-
centration of Synaptobrevin 2 in the ceramide-rich domains is well
below the sensitivity of our setup (~1 molecule/µm2). This result is
consistent with studies that show that the ceramide-rich phase is cha-
racterized by a high degree of structural order [17,43], and the tight
packing of the saturated lipid molecules might lead to the exclusion of
bulky membrane components.
AFM imaging shows that the Synaptobrevin 2 clusters included in
large Lo domains are very often surrounded by small lipid islets exhi-
biting amembrane height comparable to the Ld phase (see, for example,
the arrow in Fig. 1A). If such islets are small compared to the optical
resolution, they cannot be distinguished from the large Lo domains by
means of ﬂuorescence imaging. In this case, the ﬂuorescent signal
measured positioning the laser focus in the Lo phase could also include
photons originating fromproteinswhich are in fact surrounded by lipids
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probably connected to the presence of the bulky membrane protein,
might bias the estimation of the partition coefﬁcient between Ld and Lophases obtained from ﬂuorescence microscopy without auxiliary high-
resolution AFM data.
3.2. Enrichment of raft-associated membrane components in ceramide
domains
3.2.1. GPI-PLAP is enriched in ceramide domains
Many membrane proteins are tethered to the exoplasmic leaﬂet of
plasma membranes via a post-translational lipid modiﬁcation known
as the glycosylphosphatidylinositol (GPI) anchor [44,45]. GPI-an-
chored proteins perform their function by association with raft do-
mains in vivo [46–49]. Therefore, we chose to study the organization
of GPI-PLAP in the presence of Ld, Lo and ceramide domains, as a
paradigm for raft-associated proteins.
We reconstituted GPI-PLAP in supported bilayers with Ld/Lo/
ceramide-enriched phase coexistence, as reported above for the
Synaptobrevin 2 experiments. The activity of the protein was veriﬁed
as described in the Materials and methods section. AFM imaging shows
the three lipid phases and the protein molecules (Fig. 2A). The lowest
(Ld) phase is represented in black, the middle-height (Lo) phase in dark
grey and the high ceramide domains in light grey. As for the case of
Synaptobrevin 2, the sharp high topographical features observed prob-
ably represent a small fraction of the reconstituted protein, in form of
clusters and aggregates, which can be easily detected by AFM due to
their lowmobility [33]. The half height radii of these particles are larger
than those observed in the case of Synaptobrevin 2. They range from
15 nm to 160 nm, the largest values being observed in the ceramide-rich
domains. The presence of large aggregates in the ceramide phase is
unlikely to be an artifact, since it is reproducibly observed in the case of
GPI-PLAP but not when Synaptobrevin 2 is reconstituted in the same
lipid mixture (see Fig. 1A). As mentioned above, AFM is employed here
only to distinguish the different lipid domains and to monitor the pre-
sence of protein aggregates. In order to investigate quantitatively the
partitioning of GPI-PLAP in ceramide domains, we applied ﬂuorescence
microscopy and scanning FCS simultaneously on the same sample.
Fig. 2B shows LSM imaging of the bilayer using BODIPY-CholE enriched
in the Ld phase (green channel) and rhodamine-labeled GPI-PLAP (red
channel). The Lo domains appear dark in the green channel. The red
circles indicate ceramide-rich domains, localized via AFM imaging.
The ﬂuorescence intensity in the red channel indicates, in a qualitative
way, that the GPI-PLAP is not excluded from the ceramide-rich domains.
In order to quantitatively determine the partition coefﬁcient of the GPI-
PLAP in the different lipid phases, we measured its local concentration
using scanning FCS. The arrow in Fig. 2B indicates a typical linear path
in the plane of the membrane through which the focal volume was
scanned in a continuous way, collecting the signal from the protein
in the different phases. Between 103 and 104 lines were collected in
ca. 200 s and arranged along they-axis as shown in Fig. 2C. Therefore the
y-axis denotes the position within each line scan, while the x-axis
denotes the different acquired lines and is proportional to the time. TheFig. 2. GPI-PLAP is enriched in ceramide domains. A) AFM topographical image of a SM/
DOPC/ceramide/cholesterol supported bilayer containing GPI-PLAP at 25 °C. The three
topographical levels in the ﬁgure are represented in black (Ld phase), dark grey (Lo phase),
and light grey (ceramide-enriched phase). The protein can be visualized as white
protrusions, a few nm higher than the lipid membrane, probably corresponding to slowly
diffusing protein cluster/aggregates. B) LSM ﬂuorescence imaging of the same sample. The
green channel refers to the BODIPY-CholE in the Ld phase, and the red channel refers to the
ﬂuorescent GPI-PLAP. Red circles indicate ceramide-rich domains identiﬁed via parallel
AFM imaging. The arrow represents the scanning path used for scanning FCS (see text).
Scale bar=2 μm. C) Complete visualization of all the scanning FCS lines collected in 300 s.
Each line is represented vertically, as indicated by the black arrow. The lines are collected in
the same part of the sample indicated by the arrow in panel B. The color code refers to the
number ofmeasured ﬂuorescence photons. The white rectangles are examples of selected
line portions used to calculate autocorrelation curves. D) Normalized partitioning of GPI-
PLAP into different lipid phases (see text). In black, the partition measured in samples
without ceramide (Ld Lo phase coexistence); in grey, the partition of the protein in sample
containing ceramide (Ld/Lo/ceramide-rich phase coexistence).
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stored and represented. The different phases are clearly visible along the
y-axis as stripeswithdifferentﬂuorescence intensities. Interestingly, the
high signal from the protein in the ceramide-rich domain (located
approximatively in the center of the line scan) decreases with time
because of strong localized bleaching. As conﬁrmed by z-scan FCS (data
not shown), the diffusion coefﬁcient of the protein in the ceramide-rich
domains is below our instrumental limit (bb0.01 µm2/s), while the
diffusion in both Ld and Lo phases is similar to what measured in the
absence of ceramide domains [33,29].
At this point, it is possible to select portions of the scan path (e.g.,
the white rectangles in Fig. 2C for the Ld phase) and calculate the
autocorrelation curve, therein for each line scan. The amplitudes of the
individual autocorrelation curves were corrected for bleaching as
explained in the Materials and methods section. From the amplitude
of the average autocorrelation curve we obtained the concentration of
GPI-PLAP in the different membrane domains. Fig. 2D shows the
normalized partition P of the protein in each lipid phase (see Eqs. 1
and 2). In the case of simple Ld/Lo phase separation, PLo of GPI-PLAP is
~70%. This value is higher than what we previously measured for the
same kind of protein in an analogous experiment (i.e., 40±5%) [33].
We argue that the difference might be attributable to: i) the more
accurate puriﬁcation procedure we performed for the GPI-PLAP used
in this work (see Materials and methods) and/or ii) the statistical
variation in saturation and length of the acyl/alkyl chains in the GPI
moiety between different protein batches.
In bilayers showing Ld/Lo/ceramide-rich phase separation, PCer of
GPI-PLAP was almost ~90%. Considering that the AFM data indicate a
certain degree of protein aggregation in the ceramide-rich phase, this
value may be underestimated because large GPI-PLAP clusters might
appear as single (bright) particles in the scanning FCS measurements,
thus lowering the apparent protein concentration.
Finally, it is worth noting that simple comparison of ﬂuorescent
intensities coming from the different lipid phases would lead to an
almost 10-fold underestimation of the GPI-PLAP enrichment in the
ceramide domains (data not shown). In general, the partition coefﬁ-
cients derived from ﬂuorescent intensities are signiﬁcantly different
from those derived from FCS-measured concentrations in all of the
samples we have examined. This effect comes from the fact that the
brightness of the same ﬂuorophore in different lipid phases can
change because of several factors, such as selective photo-excitation or
environment-sensitive quenching [50]. While these changes in
ﬂuorescence quantum yield can bias partition coefﬁcients as mea-
sured using ﬂuorescence imaging, they do not, however, affect those
measured employing FCS or scanning FCS, which directly probe the
concentrations of ﬂuorophores.
In conclusion, these results showed that GPI-PLAP is strongly
enriched in the ceramide domains where its diffusion is dramatically
decreased.
3.2.2. Cholera toxin is enriched in ceramide domains
The B-subunit of cholera toxin (CTx-B) binds to the ganglioside GM1
and therefore is used as a typical marker for raft domains in cell and
model membranes [51,52]. In order to study the afﬁnity for ceramide-
rich domains of this protein that binds to raft lipids, we used the same
methodology described above for GPI-PLAP. Fig. 3A shows the ﬂuore-
scence image of a supported bilayer containing SM, DOPC, cholesterol,
and GM1 (1:1:0.67:0.27 ·10−3 molar ratio). This lipid composition dis-
plays a simple Ld/Lo phase coexistence and DiD (red channel) was
included to visualize the Ld phase [33]. Under these conditions, the
green ﬂuorescent CTx-B binds uniformly to the Lo phase, as shown in
Fig. 3A. The arrows in Fig. 3A indicate examples of occasional lipid
aggregates or non-fused vesicles which appear bright in both the red
and the green channels.
When SM is partially substituted with C18:0 ceramide, as des-
cribed above for the Synaptobrevin 2 or GPI-PLAP experiments, theCTx-B is still enriched in the portions of the membrane that exclude
DiD, but its spatial distribution is no longer homogeneous in such
domains (Fig. 3B). As shown by parallel AFM imaging of the same
supported membrane (Fig. 3C), CTx-B seems to be concentrated in the
ceramide-rich domains, that are ca. 1.2 nm higher than the Ld phase
enriched in DiD. Using scanning FCS, as described above for the GPI-
PLAP experiments, we calculated the normalized partition P of CTx-B
for the different lipid domains, both in the absence of ceramide (Ld/Lo
phase coexistence) and in the presence of ceramide (Ld/Lo/ceramide-
rich phase coexistence). As shown in Fig. 3D, more than 80% of the
CTx-B molecules partition to the ceramide-enriched domains.
Again, the strong localized bleaching of the protein in the ceramide
domains, observed both in z-scan (data not shown) and scanning FCS,
suggests strongly hindered local dynamics. Hence we conclude that,
similarly to what was observed for GPI-PLAP, the GM1-bound CTx-B is
highly concentrated and diffuses very slowly (bb0.01 µm2/s) in cera-
mide-rich domains.
The fact that both these membrane components are enriched in
the ceramide phase is a surprising result. Firstly, while the lipid chains
of the GM1 to which CTx-B is bound are long and saturated, the GPI
anchor of PLAP possesses both C18:0/C18:1 or C18:0/C16:0 lipid chains
in different proportions (see Table 1 and Fig. 1 in Ref. [53]). One could
expect that the presence of unsaturated acyl chain might disrupt the
ordered lipid packing in the ceramide-rich gel phase, if the C–C double
bond is buried deep enough in the hydrophobic core of themembrane.
Secondly, even though the partitioning of GM1 into the ceramide
domains could be favored by increased chain–chain interactions or
hydrogen-bond formation between the sphingosine backbones of
GM1 and Cer or SM [54], the bulky hydrophilic moieties of both CTx-B
and GPI-PLAP might perturb the hydrogen-bond network [5] around
the polar head groups of the lipids constituting the ceramide-rich
domains.
Nevertheless, the partitioning of GPI-PLAP and the GM1-CTx-B com-
plex into the ceramide-richdomains seems to beenergetically favorable,
at least at the low protein concentrationwe used. At these protein:lipid
ratios, neither the conformational nor the translational order of the
ceramide-rich phase are strongly perturbed, as measured by AFM and
FCS, respectively. The observation that some raft-associated molecules
are enriched in ceramide domains can be rationalized if the molecular
mechanism behind the selective inclusion/exclusion in ceramide-rich
domains arises from physical characteristics common to both Lo and
ceramide-rich phase. For example, changes in hydrophobicity and
bilayer thickness, both increasingwhen going from Ld to Lo to ceramide-
rich phase, might be involved in the speciﬁc partitioning behavior on
some membrane components [55].
Interestingly, upon ceramide generation, clustering of GPI-CD40
and strong co-localization with CTx-B was observed in in vivo studies
[22]. The same observations were made in the case of the GPI-an-
chored CD48 receptor [56]. According to these ﬁndings and to our
results in model membranes, the production of ceramide in already
existing sphingolipid-rich Lo domains might result in the formation of
ceramide-rich signaling microdomains. These domains may in turn
trigger the clustering of receptors that were already in raft-like do-
mains, and modify their diffusion behavior. Trapping of these recep-
tors in ceramide domains and subsequently reducing their diffusion
could favor sustained signaling from the membrane.
3.3. Fluorescent lipid analogues with different afﬁnities for the Lo phase
are excluded from ceramide domains
For the membrane components we have examined thus far, the
partitioning between the Ld and Lo phases seems to be important in
determining the afﬁnity for the ceramide-rich phase. In order to deter-
mine whether partitioning of a membrane component in the ceramide
domains is solely dependent on its afﬁnity for the Lo phase, we analyzed
several ﬂuorescent lipids with different partition behavior between the
Fig. 3. CTx-B is enriched in ceramide domains. A) LSM ﬂuorescence image of a SM/DOPC/cholesterol supported bilayer at 25 °C. The red channel refers to the DiD in the Ld phase, and
the green channel refers to the CTx-B enriched in the Lo phase. The arrows indicate small lipid aggregates or non-fused vesicles which appear bright in both the red and the green
channels. Scale bar=2 µm. B) LSM ﬂuorescence image of a SM/DOPC/ceramide/cholesterol supported bilayer containing the same ﬂuorescent probes as in panel A. The solid black
rectangle indicates the zone of the bilayer imaged by AFM at the same time. The dotted rectangle helps the comparisonwith panel C. Scale bar=2 µm. C) AFM topographical image of
the same bilayer shown in the black rectangle in panel B and the relative cross section. D) Normalized partitioning P of CTx-B into the different lipid phases. The values are calculated
as the local concentration normalized with the sum of the concentrations in each phase. In black, the partition measured in samples without ceramide (Ld/Lo phase coexistence); in
grey, the partition of the protein in sample containing ceramide (Ld/Lo/ceramide-rich phase coexistence).
1361S. Chiantia et al. / Biochimica et Biophysica Acta 1778 (2008) 1356–1364Lo and Ld phases. The PLo of the ﬂuorescent analogues we used ranged
from ~0.4% (DiD [33]) to ~45% (the ﬂuorescent sterol BODIPY-FChol) for
membranes showing simple Ld/Lo phase coexistence. We incorporated
theﬂuorescent lipids in supported bilayers containingDOPC, SM, C18:0-
Cer and cholesterol in a 1:0.7:0.3:0.67 molar ratio. Fig. 4A shows, in thered channel, the signal fromDiD and, in the green channel, that from the
BODIPY-FChol. Interestingly, the ﬂuorescent sterol is almost homo-
genously distributed in the entire membrane, with the exception of the
ceramide-rich domains. Both the Lo and ceramide-rich phases appear
dark in the red channel.
Fig. 4. Common ﬂuorescent lipid analogues are excluded from ceramide domains. A) LSM ﬂuorescence image of a SM/ceramide/DOPC/cholesterol supported bilayer at 25 °C. The
green channel refers to BODIPY-FChol and the red channel refers to DiD. The dark zones in both channels are ceramide-rich domains. Scale bar=2 μm. B) Normalized partitioning of
BODIPY-FChol and DiD into different lipid phases. For each ﬂuorescent dye, the normalized partitioning is indicated both in case of Ld/Lo phase coexistence (−Cer) and Ld/Lo/ceramide-
rich phase coexistence (+Cer).
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lipids for the three examined lipid phases obtained with scanning FCS.
Interestingly, both DiD and BODIPY-FChol show a very low afﬁnity for
the ceramide-rich domains, although their partitioning in the Lo phase is
dramatically different and almost half of the BODIPY-FChol partitions in
the Lo phase in samples without ceramide. A low extent of partitioning
into ceramide domains was also observed for BODIPY-CholE [14],
BODIPY-C5-Cer, and BOPIDY-DPPE. For all three dyes, we also observed a
signiﬁcant extent of partitioning into the Lo phase, with a PLo as high as
~25% for BODIPY-C5-Cer [33]. Similarly, Silva et al. observed the exclu-
sion of many ﬂuorescent dyes from C16:0 ceramide-rich domains, with
the only exception being trans-parinaric acid [17].
The high PLo of BODIPY-FChol in membranes displaying Lo/Ld phase
coexistence, although still less than 50%, suggests that this ﬂuorescent
lipid is a reliable probe for non-labeled, natural cholesterol in opticalmicroscopy, compared to other available ﬂuorescent sterol analogues (see
also [57]). In spite of its favorable interactions with SM (i.e., a relatively
high PLo), this ﬂuorescent sterol is nevertheless excluded from ceramide-
rich domains, in analogywith the case of non-labeled cholesterol [58]. It is
worth noting that, to the best of our knowledge, this is the ﬁrst direct
optical visualization of the ceramide-induced cholesterol displacement
hypothesis [59].
These results suggest that the afﬁnity for Lo domains might be
necessary for inclusion in ceramide-richdomains, but doesnot appear to
be in general sufﬁcient, as exempliﬁed by BODIPY-FChol.
4. Conclusions
We have investigated the inﬂuence of ceramide in the lateral
organization of several membrane components in supported bilayers
1363S. Chiantia et al. / Biochimica et Biophysica Acta 1778 (2008) 1356–1364showing Ld/Lo/ceramide-rich phase separation. Our results show for
the ﬁrst time in a model, well-controlled system, that some mem-
brane proteins are preferentially distributed into ceramide-rich do-
mains. More speciﬁcally, the raft-associated proteins GPI-PLAP and
CTx-B are enriched in the highly ordered ceramide-rich domains,
while several ﬂuorescent lipid analogues and the Ld-associated pro-
tein Synaptobrevin 2 are excluded from them. Furthermore, the in-
clusion of a membrane component in ceramide-rich domains is
directly connected to a dramatic reduction of its in-plane diffusion. On
the other hand, the diffusion of non raft-associated components or of
the raft-associated ones in both Ld and Lo phases are not strongly
inﬂuenced by the presence of ceramide-rich domains, in agreement
with previous measurements [14].
In an in vivo context, such a reorganization of membrane recep-
tors might be used by the cell to alter the signaling process. For
example, ceramide platforms could i) exclude inhibitors with lower
raft afﬁnity (e.g. CD45 inhibiting GPI-CD40 [22]), ii) bring in closer
contact receptors and signaling molecules both raft-associated
(e.g., FCγRII and Lyn kinase [21]), or iii) stabilize the interactions
between a receptor and its ligand by decreasing their diffusion
coefﬁcients [60]. Our data support these scenarios, as the membrane
components we examined displayed a strong ceramide-induced
alteration of their local concentration (see i) and ii)) and their diffu-
sion behavior (see iii)), in connection to their afﬁnity toward the raft-
like phase.
The ﬁnding that ceramide production protects cells from HIV
infection [61] might also be interpreted according to our results. Upon
sphingomyelinase action, the raft-associated receptor CD4 is clustered
and its diffusion is slowed [62]. Interestingly, in agreement with our
ﬁndings in the simple model we used, the mobility of the nonraft-
associated co-receptor CCR5 is not affected by ceramide production
[62]. It is thus possible that CD4 is sequestered in ceramide-enriched
domains, where its mobility is drastically reduced and the partitioning
of the non raft-associated CCR5 is extremely low [63]. Since HIV fusion
requires receptor mobility and contact between CD4 and CCR5,
immobilizing CD4 in ceramide-rich domains most likely inhibits viral
fusion at the step of co-receptor engagement [63–65]. A deeper
understanding of such amechanism obviously requires further studies
involving the reconstitution of more complex membrane proteins (for
example, with the puriﬁed CD4 receptor).
In conclusion, we used a combined approach of AFM, LSM, and
scanning FCS to probe the partition behavior of different membrane
components in the presence of raft-like and gel-phase, ceramide-rich
domains. Our results show that only some raft-associated components
were enriched and immobilized in ceramide domains. The Ld-asso-
ciated protein Synaptobrevin 2 and many lipid analogues with diffe-
rent afﬁnity toward the Lo phase were almost completely excluded
from ceramide-rich domains. Similar rearrangements of membrane
proteins may be of crucial importance in regulating signal transduc-
tion in biological contexts in which ceramide is produced in the cell
membrane.
These results also show that the combined approach of AFM and
scanning FCS on supported lipid bilayers of increasing complexity is a
promising tool for understanding the molecular mechanisms behind
ceramide-induced reorganization of membrane components in living
cells.
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